COMMUNIQUÉS West-GlobeNewswire

Surgery Partners, Inc. to Present at Wells Fargo Securities 2018 Healthcare Conference
04/09/2018
NASHVILLE, Tenn., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners”), a leading healthcare services company, today announced that Tom Cowhey, Chief Financial Officer will [...]
Zenith Epigenetics Announces Publication of a Case Study From its Ongoing mCRPC Clinical Study
04/09/2018
CALGARY, Alberta, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Zenith Epigenetics Ltd. (“Zenith” or the “Company”), a wholly-owned subsidiary of Zenith Capital Corp., announced today the publication of a scientific article on the [...]
Resverlogix Presents at Clinical Trials in Alzheimer’s Disease (CTAD) Asia 2018
04/09/2018
Dr. Jeffrey Cummings presents potential new therapy in dementia CALGARY, Alberta and SHANGHAI, Sept. 04, 2018 (GLOBE NEWSWIRE) -- As a follow up to its July 17, 2018 news release , Resverlogix Corp. (“Resverlogix” or [...]
Opiant Pharmaceuticals Announces Final Patient Enrolled in Phase 2 Clinical Trial Evaluating OPTN001 in Bulimia Nervosa
04/09/2018
Top-line Results Expected in First Quarter of 2019 SANTA MONICA, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing [...]
Altimmune Announces Additional Positive Data from Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine
04/09/2018
Six-month data demonstrates: A statistically superior mucosal immune response providing a first line of defense against infection; A durable serum immune response at six months compared to over 50% decline with Fluzone [...]
Tabula Rasa HealthCare Acquires Mediture and eClusive
04/09/2018
Mediture’s Electronic Health Record software solution and eClusive’s third party administrator services will expand TRHC’s presence in the PACE market and with other At-risk Providers MOORESTOWN, N.J., Sept. 04, 2018 ( [...]
BrainStorm Appoints Arturo Araya as Chief Commercial Officer
04/09/2018
Mr. Araya was Global Head of Commercial of Novartis Cell & Gene Therapies Unit Appointment strengthens leadership team with nearly 20 years of global pharmaceutical marketing and commercialization experience NEW [...]
Alavida continues rapid expansion across Canada: Now in Manitoba
04/09/2018
WINNIPEG, Manitoba, Sept. 04, 2018 (GLOBE NEWSWIRE) -- On the heels of their most recent financial raise, Alavida Health - a science-based innovative outpatient treatment for Heavy Drinking, expands its operations to [...]
Vistin Pharma ASA : Q2 2018 presentation
04/09/2018
Oslo, Norway, 4 September 2018 Reference is made to the release of the second quarter 2018 results on 30 August 2018 for Vistin Pharma ASA. Please find attached the investor presentation held today at Carnegie in [...]
Sanofi: Disclosure of trading in own shares
04/09/2018
Attachment Reporting EN.pdf
Sanofi : Déclaration des transactions sur actions propres
04/09/2018
Pièce jointe Reporting FR.pdf
Biogen Enrolls First Patient in Global Phase 3 Study of BIIB093 (IV Glibenclamide) for Large Hemispheric Infarction
04/09/2018
CHARM study will evaluate IV glibenclamide for the prevention and treatment of severe cerebral edema in LHI, one of the most severe types of ischemic stroke with limited treatment options Prior studies demonstrated IV [...]
Ziopharm Oncology Announces Scott Braunstein, M.D., Operating Partner at Aisling Capital, Nominated to Board of Directors
04/09/2018
BOSTON, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP) today announced that its Board of Directors has nominated Scott Braunstein, M.D., an Operating Partner at Aisling Capital, a leading [...]
Apellis Pharmaceuticals Announces that All Four Severely Anemic Soliris™-Treated Patients with Paroxysmal Nocturnal Hemoglobinuria in Ongoing Phase 1b Trial Have Been Transitioned to APL-2 Monotherapy
04/09/2018
PHAROAH Trial Results to-Date Show APL-2 Monotherapy Eliminated Transfusion Dependency and Improved Markers of Anemia in PNH Patients on Soliris™ CRESTWOOD, Ky. and WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- [...]
Mustang Bio Announces Presentations on CAR T Therapies at 4th Annual CAR-TCR Summit 2018
04/09/2018
NEW YORK, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a Fortress Biotech (NASDAQ: FBIO) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]
AxoGen, Inc. Appoints Angelo G. Scopelianos, Ph.D. as Vice President, Research and Development
04/09/2018
ALACHUA, Fla., Sept. 04, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, today announced [...]
BeyondSpring to Present at the H.C. Wainwright 20th Annual Global Investment Conference
04/09/2018
NEW YORK, Sept. 04, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI), a global, clinical-stage biopharmaceutical company focused on the development of transformative cancer therapies, today announced that [...]
RedHill Biopharma Announces Completion of Enrollment for Confirmatory Phase III Study with TALICIA® for H. pylori Infection
04/09/2018
Top-line results from the randomized, double-blind confirmatory Phase III study (ERADICATE Hp2 study) with TALICIA ® are expected before year’s end The ERADICATE Hp2 study enrolled 455 patients with confirmed H. pylori [...]
Aeglea BioTherapeutics Announces Positive Interim Clinical Data and Completion of Enrollment for Ongoing Phase 1/2 Trial of Pegzilarginase in Patients with Arginase 1 Deficiency
04/09/2018
Exceeded Enrollment Target with 15 Patients in Phase 1/2 Trial Additional Interim Data to be Presented at ASHG Conference in October 2018 Company Plans to Announce Pivotal Trial Design in Q4 2018 and Initiate Pivotal [...]

Pages